Robert Ellis, MD
Orthopaedic Surgery · Oxford, MSNPI 1316467277
Payments from drug & device makers
What this record shows
This record is dominated by education: $13,915 of the $17,084 with a category attached, or 81.5%. Smith+Nephew accounts for 79.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $7,418 and has fallen 95.9% since, to $303 in 2025.
Across 53 payments — averaging $322.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$14K
- Zimmer Biomet$1K
- Johnson & Johnson$850
- Medical Device Business Services, Inc.$529
- Stryker$346
- Nalu Medical, Inc.$112
- plus $357 from 10 others
What the payments were for
- Grants$3462%
- Travel & lodging$3132%
- Food & beverage$2,51115%
- Education$13,91581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $13,500 |
| Zimmer Biomet | 17 | $1,390 |
| Johnson & Johnson | 13 | $850 |
| Medical Device Business Services, Inc. | 4 | $529 |
| Stryker | 1 | $346 |
| Nalu Medical, Inc. | 1 | $112 |
| Seaspine Orthopedics Corporation | 1 | $84 |
| Pacira Pharmaceuticals Incorporated | 4 | $73 |
| Bioventus LLC | 2 | $40 |
| Gentleman Orthopedic Solutions | 1 | $37 |
| Vertex | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $28 |
| Boston Scientific | 1 | $23 |
| Mindray DS USA, Inc. | 1 | $16 |
| Sanara Medtech Inc. | 1 | $15 |
| Elite Orthopedics, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$780
- NONE$346
- Avenir$274
- G7$274
- ATTUNE$228
- Kincise Surgical Automated System$218
- ROSA$150
- Oxford-Knees$129
- OSSEOTITE$126
- Nalu Neurostimulation System$112
- ACTIS$104
How this compares
$17,084 in reported general payments places this provider in the 75th percentile of 170 orthopaedic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 207 | $2,275 |
| Gabapentin | 132 | $1,093 |
| Cefadroxil | 103 | $850 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 138 | $750 |
| Methocarbamol | 97 | $640 |
| Meloxicam | 117 | $298 |
| Cyclobenzaprine Hcl | 69 | $278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 40 | $276 |
| Methylprednisolone | 29 | $219 |
| Diclofenac Sodium | 28 | $205 |
| Tramadol Hcl | 56 | $127 |
| Ondansetron OdtOndansetron | 11 | $74 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $62 |
| Pantoprazole Sodium | 13 | $58 |
| Ondansetron Hcl | 27 | $47 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Oxford
- Allen MooreOxford$21K
- Matthew GravesJackson$1.2M
- George van OstenTupelo$322K
- Edward HobgoodJackson$267K
- Hanna MitiasNew Albany$249K
- Stephen SouthworthTupelo$160K
- Jamey BurrowJackson$130K
- Jeff AlmandJackson$109K
- Spencer MontgomeryJackson$90K
- Larry FieldJackson$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.